MarkWide Research - Global Market Intelligence Platform
Report Details
Historical Year
2020-2024
Base Year
2025
Forecast Period
2026-2036
Published Date
May 2026
No. of Pages
191 Pages
Delivery Format
PDF + Excel
Home›Industries›Food & Beverages›Nutritional Supplements›Middle East and Africa Nutraceutical Excipients Market

Middle East and Africa Nutraceutical Excipients Market Size, Share, and Industry Trends Forecast 2026-2036

The Middle East and Africa Nutraceutical Excipients Market valued at $187.4 Million in 2026 is forecast to scale to $397.04 Million by 2035, progressing at a 8.70% CAGR throughout the forecast period. Pharmaceutical-grade excipient adoption is accelerating across dietary supplement manufacturing in South Africa. Saudi Arabia's SFDA tightening of excipient purity protocols is reshaping import compliance requirements. Demand concentrates in Nigeria's expanding functional food processing corridor.

Middle East and Africa Nutraceutical Excipients Market Foresight

Aftermarket technical service revenue is fragmenting across the Middle East and Africa nutraceutical excipients landscape as local compounders seek formulation support closer to production sites. Kerry Group leverages its regional application labs to sustain direct relationships with capsule manufacturers in Egypt and Morocco. BASF SE anchors its position through pharmaceutical-grade polymer supply to Gulf Cooperation Council tablet producers. Evonik Industries differentiates via silica-based glidant technology leadership for high-humidity climates.

Nutraceutical excipients comprise pharmacologically inactive substances— including binders such as microcrystalline cellulose, disintegrants like croscarmellose sodium, and film-coating polymers— formulated to stabilize active ingredients, control release profiles, and ensure manufacturability of dietary supplements and functional foods. Binders and fillers occupy the largest volume share across the region due to their universal requirement in tablet and capsule production, while coating agents represent the fastest-expanding margin pool as Gulf manufacturers invest in enteric and controlled-release capabilities for heat-sensitive probiotics and omega-3 formulations. Pharmaceutical-grade material commands premium positioning over food-grade alternatives, reflecting SFDA and Egypt's Drug Authority tightening of excipient certification requirements for products claiming health benefits.

SFDA guidelines, Egypt's Drug Authority excipient monographs, and South African Health Products Regulatory Authority registration pathways collectively determine market access timelines and purity benchmarking for imported excipient stocks. These frameworks push distributors toward pre-certified supply arrangements with European and Indian manufacturers, raising working capital requirements for regional traders. Stakeholders must monitor harmonization momentum between Gulf national regulators and broader African Medicines Agency standards, as divergence in acceptance criteria for novel plant-based excipients threatens to fragment procurement strategies across the region's two largest demand clusters.

Middle East and Africa Nutraceutical Excipients Market Size and Forecast

Market Dynamics

SFDA tightening of excipient purity protocols is compressing import compliance timelines and forcing Gulf manufacturers toward pre-certified European supply arrangements, fundamentally restructuring procurement working capital requirements across the Middle East and Africa nutraceutical excipients landscape.

Growth Catalysts

  • SFDA Pharmaceutical-Grade Mandates:Saudi Arabia's excipient certification requirements for health-benefit claims are elevating demand for pharmaceutical-grade binders and disintegrants in tablet manufacturing.
  • Functional Food Processing Expansion:Nigeria's corridor of food-grade to pharmaceutical-grade upgrading is driving volume requirements for film-coating polymers in omega-3 and probiotic formulations.
  • Enteric Coating Technology Adoption:Heat-sensitive active ingredient protection needs in high-humidity Gulf climates are accelerating controlled-release capability investments among capsule producers.

Market Restraints

  • Import Dependency Concentration:Pre-certified supply arrangements with European and Indian manufacturers concentrate procurement risk in external geographies beyond regional control.
  • Working Capital Intensity:Distributor pre-certification requirements raise inventory holding costs for regional traders managing SFDA and Egypt's Drug Authority compliance pathways.
  • Plant-Based Excipient Divergence:Novel plant-based alternatives face fragmented acceptance criteria between Gulf national regulators and emerging African Medicines Agency standards.

Strategic Opportunities

  • Morocco Application Lab Proximity:Technical service localization for capsule manufacturers offers margin capture currently leaking to European technical support channels.
  • South African Regulatory Harmonization:Alignment between SAHPRA registration pathways and broader African Medicines Agency standards would streamline excipient approval across sub-Saharan demand clusters.
  • Silica-Based Glidant Climate Adaptation:High-humidity formulation stability requirements create technology differentiation openings for moisture-resistant flow agents in Gulf tablet production.

Industry Challenges

  • Formulation Chemistry Expertise Scarcity:Local compounders seeking site-adjacent technical support face limited regional talent pools for excipient-active ingredient compatibility optimization.
  • Multi-Authority Certification Timelines:Parallel SFDA, Egypt's Drug Authority, and SAHPRA registration processes extend market access delays for novel excipient introductions.

Report Scope

MarkWide Research
AttributesDetails
Report TitleMiddle East and Africa Nutraceutical Excipients Market
Market Size in 2026$187.4 Million
Market Size in 2035$397.04 Million
CAGR (2026 – 2036)8.7%
Historical Year2020-2024
Base Year2025
Forecast Period2026-2036
Segmentation
Product Type: Binders, Fillers, Disintegrants, Coating Agents
Grade: Pharmaceutical Grade, Food Grade, Nutraceutical Grade, Industrial Grade
Form: Powder, Granules, Tablets, Liquids
Application: Medications, Dietary Supplements, Functional Foods, Herbal Products
Companies CoveredKerry Group, Evonik Industries, Roquette Frères, Ingredion Incorporated, BASF SE, Cargill Incorporated, DuPont Nutrition & Biosciences, Ashland Global Holdings, ADM, Others
Regions Covered
Middle East & Africa: Saudi Arabia, UAE, Qatar, South Africa, Israel, Kuwait, Oman, North Africa, West Africa, Rest of MEA

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

Middle East and Africa Nutraceutical Excipients Market Shifts & Advancements

Excipient functionality is bifurcating between commodity-grade fillers and performance-engineered delivery systems, with climate-adapted formulations and regulatory pre-certification emerging as the primary axes of supplier differentiation across Middle East and Africa manufacturing bases.

Multifunctional co-processed excipients combining binder-disintegrant properties in single-granule formats are rendering obsolete traditional multi-component blending approaches in high-volume tablet operations. Egyptian and Moroccan capsule manufacturers are adopting these compressed process-step technologies to reduce manufacturing variability. The consolidation is compressing demand for standalone microcrystalline cellulose and croscarmellose sodium SKUs in regional procurement portfolios.

SFDA's 2025 excipient monograph alignment with IPEC-PQG GMP guidelines is mandating supplier qualification documentation for all imported stocks entering Saudi pharmaceutical-grade channels. This regulatory convergence is eliminating food-grade bypass routes previously used for dietary supplement manufacturing. Gulf Cooperation Council tablet producers are responding by locking multi-year supply agreements with European manufacturers holding active pharmaceutical ingredient excipient certifications.

Buyer concentration among integrated dietary supplement brands is compressing distributor margins and unbundling technical service from material supply contracts. Regional compounders in South Africa and Nigeria are demanding standalone formulation support priced separately from excipient volumes. This disintermediation is most visible in Johannesburg and Lagos procurement offices, where direct manufacturer relationships are displacing traditional trading house intermediaries for polymer and silica-based flow agent categories.

Middle East and Africa Nutraceutical Excipients Market Segmentation

Middle East and Africa Nutraceutical Excipients Market Segment

Excipient procurement strategies across the Middle East and Africa diverge sharply by product maturity and regulatory certification tier. Pharmaceutical-grade specifications command distinct supply chains from food-grade alternatives, while form factors determine manufacturing equipment compatibility across regional production bases.

Product Type:

Mature commodity segments dominate procurement volumes, though performance-engineered categories are capturing margin expansion in Gulf tablet operations.

  • Binders:Microcrystalline cellulose and polyvinylpyrrolidone formulations provide structural integrity to compressed tablets. Egyptian and Moroccan capsule manufacturers drive concentrated demand as they scale output for export to European markets.
  • Fillers:Lactose monohydrate and starch derivatives bulk active ingredients to measurable doses. Nigeria's functional food processing corridor absorbs expanding volumes for omega-3 and probiotic fortification applications.
  • Disintegrants:Croscarmellose sodium and sodium starch glycolate accelerate tablet dissolution in gastric environments.
  • Coating Agents:Enteric polymers protect heat-sensitive actives from high-humidity degradation in Gulf climates.

Binders handle the majority of throughput; coating agents are expanding most quickly on share.

Grade:

Certification tiers stratify procurement working capital requirements and supplier qualification timelines across regional regulatory jurisdictions.

  • Pharmaceutical Grade:IPEC-PQG GMP-compliant materials meet SFDA and Egypt's Drug Authority monograph standards for health-benefit claims. Gulf manufacturers are locking multi-year supply agreements with European-certified producers to secure import clearance.
  • Food Grade:FSSAI-aligned specifications serve dietary supplement channels bypassing pharmaceutical-grade mandates. South African compounders utilize this tier for cost-sensitive vitamin premix production.
  • Nutraceutical Grade:Hybrid certification bridging food and pharmaceutical standards for emerging functional food categories.
  • Industrial Grade:Non-certified materials restricted to animal feed and cosmetic applications outside regulated health product channels.

Pharmaceutical grade commands the steepest expansion trajectory; food grade retains the largest installed base.

Form:

Physical presentation determines handling equipment requirements and moisture stability profiles across regional manufacturing climates.

  • Powder:Free-flowing particulates require silica-based glidants in high-humidity Gulf environments. Johannesburg distributors stock pre-blended powder grades to reduce on-site formulation complexity.
  • Granules:Agglomerated formats improve flow properties for high-speed tablet presses. Lagos compounders favor this form for direct compression workflows in omega-3 softgel manufacturing.
  • Tablets:Pre-compressed excipient cores enable rapid product development for regional supplement brands.
  • Liquids:Solution and suspension formats serve pediatric and geriatric dosage formulations.

Powder absorbs the dominant volume share; granules are gaining share fastest in high-throughput operations.

Application:

End-use channels segment by regulatory pathway intensity and formulation complexity requirements.

  • Medications:SFDA-mandated excipient documentation supports prescription and over-the-counter pharmaceutical production. Saudi tablet manufacturers require complete supplier qualification dossiers for every imported batch.
  • Dietary Supplements:Vitamin and mineral premixes drive bulk filler consumption across North African contract manufacturing facilities. Cairo and Casablanca production hubs specialize in export-oriented softgel and hard capsule output.
  • Functional Foods:Beverage and dairy fortification applications demand heat-stable coating technologies.
  • Herbal Products:Traditional medicine formulations utilize plant-derived excipients with variable standardization profiles.

Dietary supplements anchor regional demand volume; functional foods represent the steepest growth pathway.

Middle East and Africa Nutraceutical Excipients Market Segmentation

Need this report tailored to your region?

Request specific countries, segments, or companies — tailored to your requirements.

Regional Outlook

Price sensitivity varies sharply across the Middle East and Africa nutraceutical excipients landscape. Nigerian compounders prioritize food-grade cost efficiency, while Saudi manufacturers absorb pharmaceutical-grade premiums to secure SFDA clearance.

Saudi Arabia

SFDA pharmaceutical-grade mandates drive demand for IPEC-PQG GMP-certified binders and disintegrants. The regulator's 2025 excipient monograph alignment eliminates food-grade bypass routes for health-benefit claims. Riyadh-based tablet manufacturers lock multi-year supply agreements with European-certified producers to secure import clearance.

United Arab Emirates

MOHAP registration pathways for excipient imports concentrate procurement through Dubai's trading hubs. The emirate's free zone infrastructure supports regional redistribution to Gulf Cooperation Council markets. Jebel Ali logistics corridors handle pre-certified European polymer stocks for enteric coating applications.

South Africa

SAHPRA registration timelines determine working capital requirements for imported excipient stocks. The regulator's pharmaceutical-grade certification pushes compounders toward pre-certified supply arrangements. Johannesburg distributors stock pre-blended powder grades to reduce on-site formulation complexity for vitamin premix manufacturers.

Egypt

Egypt's Drug Authority excipient monographs reshape import compliance for capsule and tablet producers. Cairo manufacturing hubs specialize in export-oriented softgel output requiring film-coating polymers. Local compounders adopt multifunctional co-processed excipients to compress process steps in high-volume operations.

Nigeria

FSSAI-aligned food-grade specifications serve cost-sensitive dietary supplement channels in Lagos. The functional food processing corridor drives volume requirements for omega-3 and probiotic fortification applications. Local compounders favor granule formats for direct compression workflows in softgel manufacturing.

Middle East and Africa Nutraceutical Excipients Market Competitive Landscape

Capability concentration sits with European pharmaceutical-grade specialists; scale advantage sits with diversified ingredient conglomerates. The vendor base organizes around three archetypes: application-integrated technical service providers, polymer-focused material scientists, and agricultural-derivative processors. Competitive moves center on multi-year supply agreement lock-ins with Gulf manufacturers and technical service localization through regional application labs.

Within the European pharmaceutical-grade tier, BASF SE and Evonik Industries exemplify material science positioning for high-purity polymer and silica-based flow agent supply. Kerry Group represents the application-integrated archetype, anchoring regional relationships through technical service proximity. These three occupy positions reflecting divergent bets on regulatory pre-certification value versus formulation support monetization across Middle East and Africa manufacturing bases.

Leading Market Players
Kerry Group
Evonik Industries
Roquette Frères
Ingredion Incorporated
BASF SE
Cargill Incorporated
DuPont Nutrition & Biosciences
Ashland Global Holdings
ADM
Others
Please note: The company list above is for reference and is subject to change. The final study will cover 15–20 leading companies in this market, and the final selection can be tailored to the client's specific requirements.

Supply & Pricing Matrix

Overcapacity in European pharmaceutical-grade polymer production is compressing spot pricing for Gulf Cooperation Council tablet manufacturers while simultaneously elevating supplier qualification barriers through SFDA-mandated IPEC-PQG documentation. This utilization asymmetry rewards pre-certified European incumbents with pricing power while forcing regional distributors to absorb extended inventory holding costs.

Pricing Analysis

Aftermarket technical service revenue drives lifetime value capture as regional compounders unbundle formulation support from material supply contracts. Three-tier pricing structure across pharmaceutical-grade, nutraceutical-grade, and food-grade certification levels anchors procurement portfolios, with SFDA-mandated pharmaceutical-grade premiums widening against food-grade alternatives. Cost compression in food-grade channels intensifies as Nigerian functional food processors prioritize FSSAI-aligned specifications. South African vitamin premix manufacturers exhibit highest price sensitivity; Saudi tablet producers absorbing pharmaceutical-grade premiums show least.

Supply Chain Analysis

Export-control alignment with IPEC-PQG GMP guidelines restricts uncertified excipient flows into Saudi pharmaceutical-grade channels, eliminating previous food-grade bypass routes. Supply concentrates in Germany, India, and the Netherlands for certified polymer and silica-based flow agents. Regional procurement draws from microcrystalline cellulose, croscarmellose sodium, and enteric polymer feedstocks. Single-source vulnerability concentrates in European-certified manufacturers holding active pharmaceutical ingredient excipient documentation. Distribution runs through Dubai's Jebel Ali free zone corridors for Gulf Cooperation Council redistribution.

Middle East and Africa Nutraceutical Excipients Market SWOT Analysis

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

Analyst Recommendations

SFDA's 2025 excipient monograph alignment with IPEC-PQG standards constitutes a regulatory inflection that will consolidate procurement relationships around pre-certified supply arrangements, compressing margin capture for non-compliant traders.

For Market Incumbents: Build regulatory certification moats through multi-year supply agreement lock-ins with Gulf Cooperation Council tablet producers. Anchor capacity addition in Morocco application labs to capture technical service revenue currently leaking to European channels. Defend against distributor disintermediation by unbundling formulation support pricing from material volumes. For New Entrants and Emerging Players: Pursue white-space capture in Nigeria's functional food processing corridor where food-grade to pharmaceutical-grade upgrading creates volume openings. Target granule-format excipient supply for Lagos softgel manufacturers seeking direct compression workflow efficiency. Lead with standalone technical service contracts priced separately from material supply to bypass entrenched distributor relationships. For Investors and Strategic Acquirers: Capital-intensity ratios are inflecting upward across pharmaceutical-grade certification tiers as SFDA documentation requirements extend working capital cycles. Five-to-ten year viability favors application-integrated technical service providers over commodity-grade traders. Monitor harmonization momentum between Gulf national regulators and African Medicines Agency standards as inflection signal for plant-based excipient acceptance fragmentation.
Strategic Initiative Industry Significance
Multi-year Supply Agreement Lock-in Secures SFDA import clearance pathways for European-certified polymer producers.
Regional Application Lab Establishment Captures technical service margins from capsule manufacturers in Egypt and Morocco.
Pharmaceutical-grade Certification Investment Eliminates food-grade bypass vulnerability under tightened SFDA monograph standards.
Multifunctional Co-processed Excipient Development Compresses process steps for high-volume tablet operations in Cairo manufacturing hubs.
Silica-based Glidant Climate Adaptation Addresses high-humidity formulation stability requirements in Gulf tablet production.

Research Methodology

Initial hypotheses were tested against primary input from excipient procurement managers at Gulf tablet manufacturers, regulatory affairs leads navigating SFDA and Egypt's Drug Authority pathways, formulation chemists at South African compounders, and distribution channel partners in Dubai's Jebel Ali corridor, then refined against customs and trade data, IPEC-PQG certification registries, SEC filings from listed excipient suppliers, and pharmaceutical import documentation databases. Bottom-up volume estimates triangulated with top-down market sizing across certification tiers.

Demand-supply-balance framing anchored the analytical framework throughout the projection horizon, modeling segmentation across product type, grade tier, physical form, and end-use application channel alongside regional regulatory cluster variations. CAGRs derived from fitted growth curves calibrated to import volume trajectories and certification requirement phase-in schedules. Forecast inputs incorporated SFDA monograph implementation timelines and African Medicines Agency harmonization progress.

Sensitivities concentrate around regulatory acceptance divergence for novel plant-based excipients and European manufacturer capacity utilization shifts. Forecasts reflect documented assumptions regarding certification pathway adherence and import clearance velocity. Material shifts in Gulf-African regulatory harmonization momentum or IPEC-PQG guideline revision timing would require updated calibration.

Need Custom Data?

Can't find what you're looking for? Our analysts can build a custom report tailored to your exact requirements.

1,000+

Global Clients

150+

Countries Covered

65,000+

Reports Available

Frequently Asked Questions

Why Work With MWR

Trusted by 1,000+ businesses across 150+ countries for high-stakes market decisions.

Ready to access intelligence that moves business?

Browse Reports →

Trusted by Global Leaders

From Fortune-level organizations to global SMEs, we provide intelligence for high-stakes decisions.

Multi-Language Support

Research available in French, German, Spanish, Chinese, and more.

ISO & IAF Certified

Globally aligned quality standards ensuring methodological discipline and data integrity.

Competitive Relevance

Free inclusion of 3–4 additional companies of your choice in every report.

Customized Insights

Tailored intelligence for market entry, niche expansion, or competitive benchmarking.

Post-Sale Assistance

Dedicated coordination to help interpret findings and address queries post-delivery.

Cutting-Edge Methods

Structured data collection, advanced analytics, and expert validation for reliable forecasts.

Value for Investment

Credible, structured intelligence at a cost that makes strategic sense.

What Our Clients Say

"

My team needed the real numbers on AI spending for our Reinvention Services work. MarkWide delivered. No fluff, just a clear look at where the money is actually going. It saved us about three weeks of guesswork.

Accenture

"

We recently leaned on MarkWide Research for a deep dive into the evolving snacking habits within Southeast Asia. Their report on the premium biscuit segment was exceptionally detailed, providing us with the specific consumer sentiment data we needed to refine our regional flavor strategy. It wasn't just a data dump; the cultural nuances they captured helped us avoid several localization pitfalls.

Mondelez

Director of Global Consumer Insights

"

For a recent engagement in the automotive sector, we needed rigorous, independent verification of EV battery recycling capacities. MWR delivered a report that made our work easier. Their ability to segment the competitive landscape by chemical composition and regional throughput was exactly the kind of 'hard-to-find' intel that our team was looking for.

BCG

"

We were looking for a report on Xcelerator ecosystem's potential and got in touch with MarkWide's team through one of my old colleagues who worked with them in the past. Their research team was incredibly polite and were always available for us which was important for my team as this was a custom project. Their methodology for tracking industrial IoT adoption gave our R&D heads the clarity needed to prioritize our next-gen sensor development.

Siemens

Head of Industrial Digitalization

"

During a recent M&A project, we needed a fast, reliable breakdown of the Fintech landscape in Southeast Asia. MarkWide came through with a report that was actually readable and focused on the metrics that matter. It saved my team a good week of primary research, which, given our timelines, was a massive win.

KPMG

Advisory Partner

"

We tapped MarkWide Research for a deep dive into the ESG reporting software market. At Deloitte, our clients expect us to have the most current insights, and this report didn't disappoint. It provided a breakdown of the competitive field that was far more detailed than what we were expecting.

Deloitte

Lead Consultant, Sustainability Services

"

For our semiconductor division at Samsung, the supply chain forecast from MarkWide was incredibly useful. It provided a realistic outlook on raw material availability that helped us refine our production timelines. No fluff, just the data we needed to make a tough call.

Samsung

"

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarkWide Research, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer. Their customer first approach and high value engagement model have given us great analysis and excellent value for money.

3M

"

I can share that it was a positive experience wherein MarkWide Research demonstrated flexibility to adapt to our needs and delivered an excellent report that fits all our requirements. Personally, I liked the timely follow up by the team and we will definitively reach out in case more research support is required.

VITO

Buy Now